Bone involvement as presenting sign of pediatric-onset Gaucher disease

Joint Bone Spine

Volumn 78, Issue 1, 2011, Pages 70-74

  Rossi, Linda ^a   Zulian, Francesco ^b   Stirnemann, Jérôme ^c   Billette de Villemur, Thierry ^d   Belmatoug, Nadia ^e  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c HÔPITAL JEAN VERDIER   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e BEAUJON HOSPITAL   (France)

Author keywords

Bone; Childhood; Complications; Disease presentation; Gaucher disease

Indexed keywords

ARTICLE; AVASCULAR NECROSIS; BONE DEFORMATION; BONE PAIN; CLINICAL FEATURE; GAUCHER DISEASE; HEPATOSPLENOMEGALY; HUMAN; ONSET AGE; OSTEOMYELITIS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; BONE DISEASES; FEMALE; FRANCE; GAUCHER DISEASE; HUMANS; INFARCTION; MALE; MIDDLE AGED; OSTEOMYELITIS; OSTEONECROSIS; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78651104966     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.02.045     Document Type: Article

References (17)

1. Brady R.O., Kanfer J.N., Bradley R.M., et al. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest 1966, 45:1112-1115.
2. Charrow J., Andersson H.C., Kaplan P., et al. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 2000, 160:2835-2843.
3. Kaplan P., Andersson H.C., Kacena K.A., et al. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 2006, 160:603-608.
4. Sidransky E., Ginns E.I. Clinical heterogeneity among patients with Gaucher's disease. JAMA 1993, 269:1154-1157.
5. Beutler E., Grabowski G.A. Gaucher disease. The Metabolic and molecular bases of inherited diseases 2001, vol. 3:3635-3668. McGraw-Hill, New York.
6. Levrat V., Forest I., Fouilhoux A., et al. Gaucher disease in childhood. Rev Med Intern 2007, 28:S183-S186.
7. Elstein D., Abrahamov A., Dweck A., et al. Gaucher disease. Pediatric concerns. Pediatr Drugs 2002, 4:417-426.
8. Katz K., Horev G., Rivlin E., et al. Upper limb involvement in patients with Gaucher's disease. J Hand Surg [Am] 1993, 18:871-875.
9. Katz K., Kornreich L., Horev G., et al. Involvement of the foot and ankle in patients with Gaucher disease. Foot Ankle Int 1999, 20:104-107.
10. Kaplan P., Mazur A., Manor O., et al. Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase. J Pediatr 1996, 129:149-153.
11. Kauli R., Zaizov R., Lazar L., et al. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy. Isr Med Assoc J 2000, 2:158-163.
12. Grabowski G.A. Recent clinical progress in Gaucher disease. Curr Opin Pediatr 2005, 17:519-524.
13. Grabowski G.A., Leslie N., Wenstrup R. Enzyme therapy for Gaucher disease: the first 5 years. Blood Rev 1998, 12:115-133.
14. Rosenthal D.I., Doppelt S.H., Mankin H.J., et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 1995, 96:629-637.
15. Bembi B., Ciana G., Mengel E., et al. Bone complications in children with Gaucher disease. Br J Radiol 2002, 75(Suppl. 1):A37-44.
16. Allison J.W., James C.A., Arnold G.L., et al. Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR. Pediatr Radiol 1998, 28:237-240.
17. Andersson H., Kaplan P., Kacena K., et al. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1. Pediatrics 2008, 122:1182-1190.